WAIT at RT for 3 days; ADD ethyl acetate to dilute mixture; WASH with water;
ADD 3-Bromo-2-fluoroaniline (10 g, 52.63 mmol) and DCM (100 mL) under nitrogen atmosphere;
SETTEMPERATURE: Cool mixture to room temperature; CONCENTRATE: Remove solvent under vacuum;
PURIFY crude material by silica gel chromatography using 20-100% DCM/MeOH/DEA (950:45:5) in DCM as eluent; YIELD benzyl 3-(formamido(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)methyl)piperidine-1-carboxylate (1:1 mixture of diastereomers) as a foam (2.2 g, 69%), LC/MS Rt=2.64 and 2.71 min (MS m/z: 524 [M+H]+).
ADD 1.2 mL methanol and 14 mL water;
WAIT overnight;
ADD 70 mL water;
EXTRACT three times with 84 mL methyl tert-butyl ether each
ADD 1.2 mL methanol and 14 mL water; WAIT overnight; ADD 70 mL water; EXTRACT three times with 84 mL methyl tert-butyl ether each
CONCENTRATE the reaction mixture in vacuo; MAKESOLUTION by dissolving residue in MeOH; PURIFY by solid-phase extraction (SPE) using sulfonic acid (SCX) 5 g column; WASH column with MeOH; WASH column with 10% NH3/MeOH solution; COLLECTLAYER eluent containing product; YIELD free base of product.
ADD methyl 1H-indazole-6-carboxylate (865 mg, 4.91 mmol) to N,N-dimethylformamide (12 mL); ADD potassium hydroxide (840 mg, 3.05 mmol); ADD iodine (1.54 g, 5.9 mmol);
PURIFY the product by HPLC; ADD K2CO3 (0.5 g) to the combined fractions; EXTRACT with DCM (2×50 mL); DRYSOLUTION with drying agent; CONCENTRATE in vacuo; YIELD a yellow solid (101 mg, 31%).
SETTEMPERATURE 90°C; REACTION Maintain at 90°C overnight
ADD water to the mixture; EXTRACT the mixture with ethyl acetate (EA) three times; COLLECTLAYER the combined organic layers; WASH the organic layers with brine; DRYSOLUTION over anhydrous Na₂SO₄.
DETECTED by GC, GCMS, and 1H NMR analysis;
SETTEMPERATURE Cool the mixture to room temperature; CONCENTRATE Remove solvent under reduced pressure;
ADD crushed ice (40 g);
PH adjusted to 12 using 40% aqueous KOH solution;
STIR the mixture in an ice bath for 10 min; STIR the mixture at room temperature for 20 min.
REMOVAL Desiccant and solvent by filtration; PURIFY Residue via silica gel column chromatography using gradient elution from DCM/isopropanol 95:5 to DCM/isopropanol 90:10;
SETTEMPERATURE Maintain reaction temperature below 30°C;
SETTEMPERATURE Cool 45 mL dichloromethane containing 3.37 g (9 mmol) 4-chloro-3-(2,3-dichloro-4-methoxybenzyl)-5-difluoromethoxy-1-methyl-1H-pyrazole to −78°C;
ADD 18.1 mL (18 mmol) 1M boron tribromide in dichloromethane to the cooled solution;
ADD Ethyl 7,8,9-trifluoro-1-hydroxymethyl-5-oxo-5H-thiazolo[3,2-a]quinoline-4-carboxylate (0.50 g) and triethylamine (0.40 g) to dimethylsulfoxide (15 ml); SETTEMPERATURE to 75°C; STIR the mixture at 75°C for 1 hour and 30 minutes.
PURIFY residue via reverse phase prep-HPLC; COLLECTLAYER pure fractions; PH neutralize by pushing through PL-HCO3 resin.
NOACTION;
ADD 500 μl trifluoroacetic acid to a solution of 40 mg residue in 2.0 ml DCM under ice-cooling; SETTEMPERATURE to maintain ice-cooling; STIR the mixture at maintained temperature for 2 hours.
FOLLOWOTHERPROCEDURE using 2,3-dichlorophenylisothiocyanate and product of Example 203A according to Example 153B method; YIELD 95% of desired product;
EXTRACT the aqueous layer three times with dichloromethane;
COLLECTLAYER the combined organic layers;
WASH the organic layer with saturated aqueous sodium bicarbonate;
WASH the organic layer with brine;
ADD (7-Fluoro-2-oxo-1,5-naphthyridin-1(2H)-yl)acetaldehyde methyl hemiacetal (200 mg, 0.8396 mmol) to chloroform (10 mL) and MeOH (0.5 mL); ADD 1,1-dimethylethyl[(3S,4R)-3-hydroxy-4-piperidinyl]carbamate (192 mg, 1 eq.); STIR the mixture under argon atmosphere for 2 h.
REFLUX the mixture for 5 minutes after initial exothermic reaction subsides; SETTEMPERATURE to room temperature; CONCENTRATE to dryness
ADD water to the reaction mixture;
PH the mixture to 3-4 using 1.0 N HCl aqueous solution;
EXTRACT the mixture with EtOAc.
WAIT for crystallization at 0°C; FILTER the separated solid under suction; TRANSFÉRE the solid to a separating funnel.
STIR the reaction mixture at room temperature for 20 minutes; QUENCH the reaction by pouring into water; EXTRACT the mixture with dichloromethane;
CONCENTRATE the solution under reduced pressure; PURIFY the residue by column chromatography; YIELD compound 162 as an orange solid (m.p. 49°C).
MAKESOLUTION of (6,7-difluoro-3-methyl-1,2-benzisoxazol-5-yl)methanol (200 mg, 1.0 mmol) in CH2Cl2 (10 mL); SETTEMPERATURE to 0°C using ice bath; ADD NMO (235 mg, 2.0 mmol); ADD TPAP (35 mg, 0.1 mmol); STIR for 2 hours at room temperature.
ADD 40 ml thionyl chloride to a suspension of 5.55 g 5-amino-2-methoxy-4-nitrobenzoic acid in 40 ml benzene; REFLUX the mixture for 4 hours;
NOACTION; The text describes mass spectrometry results rather than procedural steps.
ADD DCM (1-2 mL) and Et2O; PRECIPITATION occurs, forming a solid
STIR the resulting slurry for 30 minutes at 25°C; PH adjust to 9 by adding 6M NaOH (0.135 L);
ADD triphenylphosphine (2.95 g) to a solution of (pyridin-2-yl)methanol (0.724 ml) in dichloromethane (40 ml) under ice cooling; ADD carbon tetrabromide (3.73 g); SETTEMPERATURE to maintain ice cooling; STIR the mixture at maintained temperature for 1.5 hr.
REACTION: Combine intermediate of Formula-11, Desloratadine, and K2CO3 in acetone; YIELD: Rupatadine base is obtained; REACTION: Treat Rupatadine base with fumaric acid in methanol; YIELD: Rupatadine Fumarate (Formula-1) is obtained.
REMOVAL; Solvent; PURIFY; By preparative-HPLC; YIELD; 2-(5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-N-(2-oxo-2-(2,2,2-trifluoroethylamino)ethyl)thieno[2,3-b]pyridine-5-carboxamide as a white solid (50 mg, 34.78%)
SETTEMPERATURE reaction mixture to ambient; ADD reaction mixture to H2O (250 mL);
MAKESOLUTION: Dissolve 4-(1-{2-fluoro-1-[(3S)-pyrrolidin-3-yl]ethyl}-1H-pyrazol-4-yl)-7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidine (25 mg, 0.058 mmol from Example 70 Step 7) and DIPEA (2.0E1 μL, 0.12 mmol) in NMP (0.2 mL);
STIR the mixture for 1.5 hours; ADD a solution containing 3-amino-4-{[3-(dimethylamino)propyl]amino}-N-methylbenzamide (1.653 g) in chloroform (9 mL) to the mixture;
MAKESOLUTION the product in a small amount of acetonitrile and ~5 mL water; FREEZING the mixture in dry ice; DRYSOLID by lyophilization to obtain a powder product; YIELD 20 mg (44.1%).
RECRYSTALLIZE the residue from 60 mL benzotrifluoride; ADD activated carbon to the mixture; SETTEMPERATURE to boiling and maintain briefly; FILTER the mixture while hot.
STIR the mixture at room temperature for 1 hour; ADD methanolic HCl periodically to maintain yellow color;
SETTEMPERATURE 0°C; WAIT 30 minutes; SETTEMPERATURE ambient temperature;
PH the remaining aqueous layer to pH=3 with 1N HCl (8 mL);
SETTEMPERATURE cool reaction in ice bath; ADD tert-Butyl 4-oxopiperidine-1-carboxylate (4.98 g) as solution in dichloromethane (20 mL); STIR reaction at room temperature for 1 hour;
STIR the mixture at room temperature for 1 hour; QUENCH with 1N hydrochloric acid; EXTRACT the mixture with ethyl acetate; COLLECTLAYER the organic phase.
NOACTION;
MAKESOLUTION Dissolve 396 mg (0.696 mmol) of Example 149-1 compound in 64 mL THF and 24 mL methanol; ADD 36 mL of 2.5% potassium carbonate aqueous solution; STIR mixture at room temperature for 6 hours;
STIR the mixture at 70°C for 15 minutes; SETTEMPERATURE to room temperature.
SETTEMPERATURE Heat to 110°C using an oil bath;
FOLLOWOTHERPROCEDURE Follow Example 34 using (3S,4R)-4-amino-piperidine-1,3-dicarboxylic acid 1-tert-butyl ester 3-methyl ester as starting material; OBTAINED Target compound from reaction with thiazolidine and 2-(2-bromo-ethyl)-pyridine (note: pyridine derivative synthesized per Synthesis, 1987, 5, 452-455)
ADD 100 g methyl ester of 4-methyl-3-cyclohexene-1-carboxylic acid in 20 ml dry tetrahydrofuran at 20°-30°C with ice bath cooling;
NOACTION; The provided text describes NMR spectral data for characterization, not a chemical procedure requiring protocol steps.
FILTER: Attempt to filter mixture (unsuccessful); WAIT: Allow mixture to stand overnight.
REMOVAL of the cooling bath; STIR the mixture at room temperature overnight;
ADD water to the reaction mixture; PH adjust to neutral by adding 2N hydrochloric acid; EXTRACT the mixture with ethyl acetate; PHASESEPARATION; COLLECTLAYER organic (ethyl acetate) phase.
FOLLOWOTHERPROCEDURE according to Procedure E and Scheme M using N-(3-{1-[5-(4-iodophenyl)-5-oxopentyl]-4-piperidinyl}phenyl)-2-methylpropanamide (X mmol) and 1-naphthylhydrazine hydrochloride (X mmol); OBSERVED ESMS m/e: 656.1 (M+H)+ for product confirmation;
PARTITION reaction mixture with ice water; WASH with diethyl ether; PH adjust to neutral using 5 M aqueous sodium hydroxide; EXTRACT twice with ethyl acetate.
ADD lithium hydride (2.3 g; 0.28 mol) in portions to a solution of 2-[(3,6-dichloro-4-pyridazinyl)oxy]ethanol containing bromo-derivative (15.46 g; 0.0703 mol) in dry 1,4-dioxane (1.2 L);
STIR the mixture at room temperature for 1 hour under argon atmosphere;
REFLUX the mixture at 110°C overnight under argon atmosphere;
ADD 2,8-Dimethyl-5-((2-(pyridin-4-yl)oxiran-2-yl)methyl)-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole (100 mg, 0.3 mmol) to 2M dimethyl amine solution in THF (5 mL); SETTEMPERATURE to 60°C; STIR reaction mixture at 60°C for 12 hours;
WAIT for 48 hours allowing reaction mixture to warm to room temperature;
ADD 6-(3-fluoro-4-methoxyphenyl)-5-(4-methoxyphenyl)-2H-pyridazin-3-one (150 mg, 0.46 mmol) to N,N-dimethylformamide (1.5 ml); ADD potassium carbonate (317.6 mg); ADD ethyl iodide (179.2 mg); SETTEMPERATURE to 70°C; STIR at 70°C for 3 hours.
ADD 3-Nitro-phenol (1.00 g, 7.189 mmol) and 4-bromo-benzyl bromide (1.976 g, 7.90 mmol) in [solvent]; FOLLOWOTHERPROCEDURE following the procedure of 189a; YIELD the title compound (2.1 g, 97%).
SETTEMPERATURE to -70°C; STIR the reaction mixture for 4 hours at -70°C; SETTEMPERATURE allow reaction mixture to warm to room temperature;
PH: Maintain pH at 9 using NaOH solution; PHASESEPARATION: Separate layers while maintaining constant pH at 9
FOLLOWOTHERPROCEDURE according to Example 15 using Intermediate 17 and 2-chloro-benzooxazole;
NOACTION;
STIR the mixture at current temperature for 60 minutes; WAIT until the mixture cools to room temperature.
EXTRACT aqueous phase with ethyl acetate (100 mL);
COLLECTLAYER organic phase;
WASH combined organic phase with water (3×100 mL) followed by saturated aqueous sodium chloride (100 mL);
DRYSOLUTION over MgSO4;
FILTER to remove drying agent;
CONCENTRATE filtrate under reduced pressure to obtain oily residue (3.9 g);
YIELD crude product (NMR: 200 MHz; CDCl3, TMS δ 7.9-7.2 m, 4.37 s, 3.60 s) for direct use in next reaction.
NOACTION;
WAIT for 20 minutes with occasional swirling; STIR occasionally;
ADD 3-allyloxy-4-methoxynitrobenzene (pale yellow solid) in portions over 30 minutes; SETTEMPERATURE to 95°C and maintain for 3 hours until starting material consumption is observed;
YIELD The title product is obtained as a red-brown solid (20.64 g, 84%);
ADD 200 mL of water to the residue;
PH adjust the solution to neutral using KOH pellets;
EXTRACT with 3 × 100 mL of CH2Cl2;
PHASESEPARATION to isolate organic layer;
COLLECTLAYER organic phase.
SETTEMPERATURE to room temperature; FILTER the precipitated product; WASH the filter cake with cold triethyl orthoformate followed by heptane; DRYSOLID under vacuum
WAIT until bubbling ceases; ADD 1N HCl; PH until ~2
SETTEMPERATURE to room temperature; WAIT overnight; QUENCH with saturated aqueous NH4Cl solution; PHASESEPARATION; COLLECTLAYER organic layer.
STIR 3-cyclobutyl-7-(piperidin-4-yloxy)-2,3,4,5-tetrahydro-1H-benzo[d]azepine (E6) (150 mg, 0.5 mmol) in dichloromethane (5 mL) with diethylaminomethyl polystyrene (3.2 mmol/g, 625 mg, 2 mmol);

BREAKDOWN:
1. ADD compound E6 to dichloromethane solvent;
2. ADD diethylaminomethyl polystyrene resin;
3. STIR mixture to facilitate reaction/interaction

(Note: The original text describes a single continuous action - stirring a mixture of two components in solvent. No filtration, heating, or workup steps are mentioned. STIR is the primary action here.)
SETTEMPERATURE to room temperature; STIR the mixture for overnight;
WASH the combined organic layers with brine;
DRYSOLUTION over sodium sulfate;
FILTER the dried solution;
CONCENTRATE the filtrate;
YIELD 2.98 g of N-{2-[4-amino-7-[(6-aminohexyl)oxy]-2-(ethoxymethyl)-1H-imidazo[4,5-c]quinolin-1-yl]-1,1-dimethylethyl}-N-isopropylurea as a dark orange solid.
WASH the combined organic layers with brine; DRYSOLUTION over sodium sulfate; FILTER the dried solution; CONCENTRATE the filtrate; YIELD 2.98 g of N-{2-[4-amino-7-[(6-aminohexyl)oxy]-2-(ethoxymethyl)-1H-imidazo[4,5-c]quinolin-1-yl]-1,1-dimethylethyl}-N-isopropylurea as a dark orange solid.
ADD 3-Amino-2,4-dichloro-benzamide (2.00 g, 9.8 mmol) to THF (45 mL);
ADD LiAlH4 (1 M in THF, 24.4 mL) to THF (45 mL);
ADD first solution to second solution dropwise;
ADD methanesulfonyl chloride (1 drop);
STIR mixture at RT for 30 min;
SETTEMPERATURE Cool reaction mixture to −80°C; ADD Solution of tert-butyl 6-[(cyclopropylmethoxy)methyl]-6-hydroxy-1,4-oxazepane-4-carboxylate (Preparation 80, 50 g, 0.22 mol, 1 eq) in THF to reaction mixture;
WAIT for a few hours; ADD water to reaction mixture; QUENCH with hydrochloric acid; FILTER mixture; RECRYSTALLIZE solid; YIELD title compound.
SETTEMPERATURE to room temperature; STIR the reaction mixture for 12 hours
SETTEMPERATURE Cool to room temperature; EXTRACT With ethyl acetate; PHASESEPARATION Separate layers;
FILTER the precipitate using vacuum filtration; WASH the collected solid with water followed by diethyl ether; DRYSOLID under high vacuum at 60°C for 4 hours; YIELD 7.02 g (63%) of 7-benzyloxy-3,4-dihydroquinazolin-4-one as a dry solid.
CONCENTRATE the solution; ADD dichloromethane (200 mL/mmol) to the residue; WASH with water (62 mL/mmol, 3×) via phase separation;
SETTEMPERATURE 60°C; STIR for 16 hours; WAIT until starting material is completely consumed.
ADD ethyl acetate (3 mL) and heptane (3 mL) to the residue; PRECIPITATION of a solid occurs.
ADD 5-(4-bromophenyl)-1-[3-fluoro-4-(methylsulfonyl)phenyl]-3-(trifluoromethyl)-1H-pyrazole (0.15 g, 0.324 mmol) to DME (3.9 mL); STIR the mixture; ADD furan-3-boronic acid (0.044 g, 0.389 mmol), bis(triphenylphosphine)palladium(II) chloride (0.025 g, 0.04 mmol), and saturated NaHCO3 solution (1.3 mL) under nitrogen atmosphere; SETTEMPERATURE to room temperature;
YIELD 1.5 g (50.34%);
REACTION of Appl. (1992), GB 2253848 A1 with [2-methyl-5-(4-trifluoromethoxy-phenyl)-2H-pyrazol-3-yl]-methanol (example 11 d); CATALYST N,N,N',N'-tetramethyl azodicarboxamide; CATALYST tributylphosphine; YIELD [rac]-2-{6-[2-methyl-5-(4-trifluoromethoxy-phenyl)-2H-pyrazol-3-ylmethoxy]-indol-1-yl}-propionic acid-ethyl ester as colorless oil.
ADD 4-bromo-3-methyl-1-(4-methylbenzenesulphonyl)-1H-pyrrole-2-carbonitrile (4.66 g, 13.7 mmol) to methanol (95 mL); SETTEMPERATURE cool using ice bath; ADD potassium hydroxide (3.65 g, 65.1 mmol) all at once;
STIR the reaction mixture for 3 hours; ADD 300 ml of water.
STIR the reaction mixture at room temperature for 92 hours; QUENCH the mixture by adding 85 mL of 2M aqueous hydrochloric acid; ADD 170 mL of water to dilute the mixture.
PURIFY the mixture directly by preparative HPLC using Method 10; YIELD the desired product.
STIR the solution in a sealed reaction vessel for 20 h; ADD EtOAc (50 mL)